Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 65
Filtrar
Más filtros

País/Región como asunto
País de afiliación
Intervalo de año de publicación
1.
Acta Anaesthesiol Scand ; 58(4): 468-77, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24617621

RESUMEN

BACKGROUND: Coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass (CPB) is associated with systemic inflammatory response and endothelial dysfunction. Our hypothesis is that CPB-induced post-operative endothelial dysfunction may be detected using laser Doppler perfusion monitoring (LDPM) in the skin microcirculation. METHODS: We used LDPM to investigate the subacute effects of the CPB on systemic microvascular reactivity among patients undergoing CABG surgery with CPB. Thirty patients were submitted to the study of skin microcirculation and blood sample collection at baseline (pre-surgery) and at 7 days post-surgical procedure. The skin microcirculation was evaluated by acetylcholine (ACh) and sodium nitroprusside (SNP) iontophoresis, and thermal hyperemia (TH). Plasma levels of nitrite/nitrate were also analyzed, and cytokine profiles were determined using a multiplex system. RESULTS: On-pump CABG surgery induced a significant reduction of the increased microvascular dermal flux observed after cumulative doses of ACh iontophoresis and after TH. On-pump CABG surgery did not induce any significant changes in the microvascular flux after cumulative doses of SNP. Patients still presented high levels of interleukin (IL)-6, IL-8, and C-reactive protein, and low bioavailability of nitric oxide 7 days after the CABG surgery with CPB. CONCLUSION: We observed a significant impairment of systemic microvascular endothelial function and well-preserved endothelium-independent vasodilatation in the skin microcirculation of patients 1 week after CABG surgery with CPB. Our results suggest that LDPM is a useful tool for the assessment of on-pump CABG-induced subacute post-operative endothelial dysfunctions.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos/efectos adversos , Endotelio Vascular/fisiopatología , Complicaciones Posoperatorias/fisiopatología , Enfermedades Vasculares/fisiopatología , Acetilcolina , Capilares/efectos de los fármacos , Capilares/fisiología , Puente Cardiopulmonar/efectos adversos , Puente de Arteria Coronaria , Citocinas/sangre , Femenino , Calor , Humanos , Hiperemia/fisiopatología , Cuidados Intraoperatorios , Iontoforesis , Flujometría por Láser-Doppler , Masculino , Persona de Mediana Edad , Nitratos/sangre , Óxido Nítrico/sangre , Nitroprusiato , Perfusión , Periodo Posoperatorio , Vasodilatadores
2.
Braz J Med Biol Res ; 57: e13624, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39194032

RESUMEN

Energy drinks are nonalcoholic beverages whose main ingredients are sugar, taurine, and caffeine. The consumption of energy drinks is increasing worldwide, but only a few conflicting studies have investigated the vascular effects of energy drinks in young adults. The aim of this study was to evaluate microvascular reactivity before and after energy drinks consumption in young healthy male volunteers. This was a cross-sectional prospective study. Microvascular reactivity signals were evaluated in the skin of the forearm using laser speckle contrast imaging with acetylcholine (ACh) iontophoresis before and 90 and 180 min after the randomized consumption of one ED or the same volume of water (control), followed by a postocclusive reactive hyperemia (PORH) test. Thirty-two volunteers were evaluated (age: 25.4±4.3 years). Energy drink consumption prevented the rest-induced reduction in cutaneous vascular conductance over time that was observed in the control group. In the control group, there were significant reductions in microvascular vasodilation at 90 and 180 min compared to baseline (P=0.004), but this was not the case in the energy drink group (P=0.76). Our results demonstrated that the reduction in microvascular conductance associated with prolonged immobility can be prevented by the consumption of one energy drink, highlighting the vasodilator effects of this beverage in young individuals at rest. The between-study variability in terms of the brand of energy drinks and the ingested volume, as well as the method of vascular evaluation and the inclusion criteria, may explain the discrepancies among previous studies on the vascular effects of energy drinks.


Asunto(s)
Bebidas Energéticas , Humanos , Masculino , Adulto , Estudios Prospectivos , Estudios Transversales , Adulto Joven , Vasodilatación/efectos de los fármacos , Vasodilatación/fisiología , Descanso/fisiología , Antebrazo/irrigación sanguínea , Microcirculación/efectos de los fármacos , Microcirculación/fisiología , Piel/irrigación sanguínea , Piel/efectos de los fármacos , Hiperemia , Microvasos/efectos de los fármacos , Acetilcolina/administración & dosificación , Acetilcolina/farmacología
3.
Microvasc Res ; 84(2): 218-21, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22659381

RESUMEN

Sepsis is a severe disorder characterized by systemic inflammatory responses in the presence of an infection and may progress to multiple organ dysfunction and death. Alterations in cerebral microcirculation fulfill a crucial role in the pathogenesis of severe sepsis, and include a decrease in capillary density and disturbances in leukocyte movement along capillaries. Nevertheless, the mechanisms involved in sepsis-associated cerebral microcirculatory alterations have so far not been defined. We investigated the effect of the peroxisome proliferator-activated receptor gamma (PPARγ) selective agonist rosiglitazone on leukocyte/endothelial cell interaction and functional capillary density in the brain in the cecal ligation and puncture (CLP) model of sepsis. Anti-inflammatory effects of rosiglitazone on the cerebral microcirculation were marked. Functional capillary density increased and leukocyte rolling and adhesion were decreased in animals submitted to CLP and treated with rosiglitazone. Our data provide evidence for involvement of PPARγ activation in leukocyte-endothelium interactions and alterations in capillary density. Improved cerebral perfusion in animals treated with rosiglitazone, suggests that PPARγ activation is protective against cerebral microvascular dysfunction in sepsis.


Asunto(s)
Antiinflamatorios/farmacología , Encéfalo/irrigación sanguínea , Circulación Cerebrovascular/efectos de los fármacos , Trastornos Cerebrovasculares/prevención & control , Microcirculación/efectos de los fármacos , Microvasos/efectos de los fármacos , PPAR gamma/agonistas , Sepsis/tratamiento farmacológico , Tiazolidinedionas/farmacología , Animales , Ciego/cirugía , Trastornos Cerebrovasculares/inmunología , Trastornos Cerebrovasculares/metabolismo , Trastornos Cerebrovasculares/fisiopatología , Citoprotección , Modelos Animales de Enfermedad , Rodamiento de Leucocito/efectos de los fármacos , Ligadura , Masculino , Ratones , Microvasos/inmunología , Microvasos/metabolismo , Microvasos/fisiopatología , Infiltración Neutrófila/efectos de los fármacos , PPAR gamma/metabolismo , Punciones , Rosiglitazona , Sepsis/inmunología , Sepsis/metabolismo , Sepsis/fisiopatología
4.
Diabet Med ; 28(10): 1188-93, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21658123

RESUMEN

AIMS: Recent data identified uric acid as an independent risk factor for cardiovascular disease. The aim of the present study was to assess the association between uric acid and endothelial dysfunction in 57 patients with Type 1 diabetes and 53 healthy control subjects. METHODS: Microvascular endothelial function was evaluated using laser Doppler perfusion monitoring coupled with pharmacological (iontophoretic administration of acetylcholine and sodium nitroprusside) and physiological (post-occlusive reactive hyperaemia and thermal hyperaemia) stimuli. RESULTS: Uric acid was higher in subjects without diabetes than in those with diabetes (P = 0.03). Microvascular vasodilator response to acetylcholine was significantly reduced in Type 1 diabetes (P = 0.002) and was correlated to disease duration (r = -0.3, P = 0.01), triglyceride (r = -0.37, P = 0.005), insulin dose (r = -0.28, P = 0.03), fasting plasma glucose levels (r = -0.3, P = 0.02), HbA(1c) (r = -0.34, P = 0.001) and uric acid (r = -0.3, P = 0.005). On stepwise multivariate analysis, age, HbA(1c) and uric acid were the most important independent variables that were associated with the endothelium-dependent response in Type 1 diabetes (P = 0.02). CONCLUSIONS: Glycaemic control and uric acid in the normal range were the most important contributing factors to the decreasing endothelium-dependent responses associated with Type 1 diabetes. Consequently, uric acid could be a new potential marker of microvascular endothelial dysfunction in these patients. Further studies are required to explore the clinical relevance of the relationship between uric acid levels, oxidative stress and endothelial dysfunction in patients with Type 1 diabetes, as well as whether treatment with uric acid-lowering drugs for slight elevations in uric acid would benefit these patients.


Asunto(s)
Glucemia/metabolismo , Diabetes Mellitus Tipo 1/sangre , Angiopatías Diabéticas/metabolismo , Endotelio Vascular/metabolismo , Microcirculación , Ácido Úrico/sangre , Adulto , Análisis de Varianza , Biomarcadores/sangre , Enfermedad de la Arteria Coronaria/metabolismo , Estudios Transversales , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 1/fisiopatología , Angiopatías Diabéticas/sangre , Angiopatías Diabéticas/tratamiento farmacológico , Angiopatías Diabéticas/fisiopatología , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/fisiopatología , Femenino , Hemoglobina Glucada/metabolismo , Humanos , Flujometría por Láser-Doppler , Masculino , Microcirculación/efectos de los fármacos , Adulto Joven
5.
Braz J Med Biol Res ; 54(6): e10577, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33886810

RESUMEN

Endothelial dysfunction is a well-known component of the pathophysiology of heart failure (HF), with proven prognostic value. Dietary supplementation with whey protein (WP) has been widely used to increase skeletal muscle mass, but it also has vascular effects, which are less understood. This study aimed to evaluate the effects of WP supplementation on the systemic microvascular function of HF patients. This was a blinded, randomized, placebo-controlled clinical trial that evaluated the effects of 12-week WP dietary supplementation on systemic microvascular function, in patients with HF New York Heart Association (NYHA) classes I/II. Cutaneous microvascular flow and reactivity were assessed using laser speckle contrast imaging, coupled with pharmacological local vasodilator stimuli. Fifteen patients (aged 64.5±6.2 years, 11 males) received WP supplementation and ten patients (aged 68.2±8.8 years, 8 males) received placebo (maltodextrin). The increase in endothelial-dependent microvascular vasodilation, induced by skin iontophoresis of acetylcholine, was improved after WP (P=0.03) but not placebo (P=0.37) supplementation. Moreover, endothelial-independent microvascular vasodilation induced by skin iontophoresis of sodium nitroprusside, was also enhanced after WP (P=0.04) but not placebo (P=0.42) supplementation. The results suggested that dietary supplementation with WP improved systemic microvascular function in patients with HF.


Asunto(s)
Insuficiencia Cardíaca , Vasodilatación , Anciano , Suplementos Dietéticos , Endotelio Vascular , Insuficiencia Cardíaca/tratamiento farmacológico , Humanos , Masculino , Microcirculación , Persona de Mediana Edad , Proyectos Piloto , Piel , Vasodilatadores/farmacología , Proteína de Suero de Leche/farmacología
6.
Braz J Med Biol Res ; 53(12): e9615, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33146287

RESUMEN

The sympathetic nervous system (SNS) plays a fundamental role in the pathophysiology of cardiovascular diseases, including primary arterial hypertension. In this study, we aimed to investigate whether the expression of the rate-limiting enzyme in catecholamine synthesis, tyrosine hydroxylase (TH), and the ß2-adrenergic receptor (ß2-AR) in immune cells from peripheral blood, reflect central SNS activity in spontaneously hypertensive rats (SHR). TH expression in the lower brainstem and adrenal glands and ß2-AR expression in the lower brainstem were analyzed by western blot analyses. In the leukocytes, TH and ß2-AR expression was evaluated by flow cytometry before and after chronic treatment with the centrally-acting sympathoinhibitory drug clonidine. Western blot analyses showed increased TH and ß2-AR expression in the lower brainstem and increased TH in adrenal glands from SHR compared to normotensive Wistar Kyoto rats (WKY). Lower brainstem from SHR treated with clonidine presented reduced TH and ß2-AR levels, and adrenal glands had decreased TH expression compared to SHR treated with vehicle. Flow cytometry showed that the percentage of leukocytes that express ß2-AR is higher in SHR than in WKY. However, the percentage of leukocytes that expressed TH was higher in WKY than in SHR. Moreover, chronic treatment with clonidine normalized the levels of TH and ß2-AR in leukocytes from SHR to similar levels of those of WKY. Our study demonstrated that the percentage of leukocytes expressing TH and ß2-AR was altered in arterial hypertension and can be modulated by central sympathetic inhibition with clonidine treatment.


Asunto(s)
Hipertensión , Animales , Presión Sanguínea , Hipertensión/tratamiento farmacológico , Leucocitos , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Receptores Adrenérgicos beta 2 , Sistema Nervioso Simpático , Tirosina 3-Monooxigenasa
7.
Braz. j. med. biol. res ; 57: e13624, fev.2024. tab, graf
Artículo en Inglés | LILACS-Express | LILACS | ID: biblio-1568971

RESUMEN

Energy drinks are nonalcoholic beverages whose main ingredients are sugar, taurine, and caffeine. The consumption of energy drinks is increasing worldwide, but only a few conflicting studies have investigated the vascular effects of energy drinks in young adults. The aim of this study was to evaluate microvascular reactivity before and after energy drinks consumption in young healthy male volunteers. This was a cross-sectional prospective study. Microvascular reactivity signals were evaluated in the skin of the forearm using laser speckle contrast imaging with acetylcholine (ACh) iontophoresis before and 90 and 180 min after the randomized consumption of one ED or the same volume of water (control), followed by a postocclusive reactive hyperemia (PORH) test. Thirty-two volunteers were evaluated (age: 25.4±4.3 years). Energy drink consumption prevented the rest-induced reduction in cutaneous vascular conductance over time that was observed in the control group. In the control group, there were significant reductions in microvascular vasodilation at 90 and 180 min compared to baseline (P=0.004), but this was not the case in the energy drink group (P=0.76). Our results demonstrated that the reduction in microvascular conductance associated with prolonged immobility can be prevented by the consumption of one energy drink, highlighting the vasodilator effects of this beverage in young individuals at rest. The between-study variability in terms of the brand of energy drinks and the ingested volume, as well as the method of vascular evaluation and the inclusion criteria, may explain the discrepancies among previous studies on the vascular effects of energy drinks.

8.
Braz J Med Biol Res ; 52(2): e8001, 2019 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-30652826

RESUMEN

There is no definite recommendation for testing platelet aggregation (PA) in acute coronary syndromes (ACS) due to inconclusive evidence on the usefulness of platelet function tests to guide therapy and improve clinical outcomes. The evaluation of PA with multiple electrode impedance platelet aggregometry (MEA) may be useful to manage antiplatelet therapy and possibly influence patient outcome. The primary aim of this study was to measure PA with MEA in Brazilian patients with ACS and evaluate the association between PA and adverse clinical outcomes. Forty-seven consecutive patients admitted with ACS to a Brazilian tertiary-care public hospital were studied and PA was evaluated using MEA. Patients were followed for six months for the occurrence of all-cause death, acute myocardial infarction, or stroke. Suboptimal inhibition of PA was found in 7 patients (14.9%); 5 (10.6%) in response to ASA (acetylsalicylic acid), 2 (5.0%) to clopidogrel, and none to ticagrelor. Inadequate PA inhibition in response to ASA was significantly associated with the composite end point, but there was no significant association for insufficient PA inhibition in response to clopidogrel. This study suggested that the evaluation of PA in ACS using MEA may identify non-responders to ASA. Larger studies are necessary to define, in a public health scenario, the value of MEA in the management of ACS.


Asunto(s)
Síndrome Coronario Agudo/sangre , Impedancia Eléctrica/uso terapéutico , Agregación Plaquetaria , Síndrome Coronario Agudo/tratamiento farmacológico , Adenosina/uso terapéutico , Aspirina/uso terapéutico , Femenino , Hospitales Públicos , Humanos , Masculino , Proyectos Piloto , Agregación Plaquetaria/efectos de los fármacos , Inhibidores de Agregación Plaquetaria/uso terapéutico , Recuento de Plaquetas , Pruebas de Función Plaquetaria , Estudios Prospectivos , Receptores Purinérgicos P2Y12/sangre , Centros de Atención Terciaria
9.
Br J Sports Med ; 42(5): 386-8, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-17717063

RESUMEN

OBJECTIVE: We have shown previously that exercise training enhances endothelium-dependent and endothelium-independent vascular relaxation in rabbit kidney. This study aimed to investigate protein expression changes in the rabbit renal cortex induced by chronic dynamic exercise. DESIGN: Kidneys were obtained from New Zealand rabbits either confined to pens (n = 8) or trained on a treadmill (0% grade) for 5 days/week at a speed of 18 m/min for 60-min periods over 12 weeks (n = 8). Expression of proteins in the renal cortex was determined by colloidal Coomassie blue staining after two-dimensional polyacrylamide gel electrophoresis. Differential protein spots were excised and digested with trypsin, and peptides were sequenced by electrospray ionization-ion trap mass spectrometry. RESULTS: Two pairs of matching differentially stained spots displayed an approximate threefold increase in trained compared with sedentary animals. These four spots presented a molecular mass of 23 kDa but different pI values. Mass spectrometric analyses revealed the pairs of matching spots as being rabbit apolipoprotein A-I. CONCLUSION: Chronic dynamic exercise increases apolipoprotein A-I expression in the rabbit renal cortex. This fact could be involved in the alterations observed in the renal circulation after exercise training.


Asunto(s)
Apolipoproteína A-I/metabolismo , Corteza Renal/fisiología , Condicionamiento Físico Animal/fisiología , Animales , Electroforesis en Gel Bidimensional , Proteómica , Conejos , Distribución Aleatoria
10.
Braz J Med Biol Res ; 51(3): e6601, 2018 Jan 11.
Artículo en Inglés | MEDLINE | ID: mdl-29340522

RESUMEN

The primary aim of this study was to evaluate penile endothelial microvascular function in patients with primary arterial hypertension and age-matched normotensive subjects using laser speckle contrast imaging (LSCI). Additionally, we analyzed the acute penile microvascular effects induced by oral phosphodiesterase type 5 inhibitor (sildenafil; SIL) administration. Endothelium-dependent microvascular reactivity was evaluated in the penises and forearms of hypertensive patients (aged 58.8±6.6 years, n=34) and age-matched healthy volunteers (n=33) at rest and 60 min following oral SIL (100 mg) administration. LSCI was coupled with cutaneous acetylcholine (ACh) iontophoresis using increasing anodal currents. Basal penile cutaneous vascular conductance (CVC) values were not significantly different between control subjects and hypertensive individuals. Penile CVC values increased significantly after SIL administration in control (P<0.0001) and hypertensive (P<0.0001) subjects. Peak CVC values were not different between the two groups during penile ACh iontophoresis before SIL administration (P=0.2052). Peak CVC values were higher in control subjects than in hypertensive subjects after SIL administration (P=0.0427). Penile endothelium-dependent microvascular function is, to some extent, preserved in patients presenting with primary arterial hypertension under effective anti-hypertensive treatment. LSCI may be a valuable non-invasive tool for the evaluation of penile vascular responses to phosphodiesterase type 5 inhibitor.


Asunto(s)
Endotelio Vascular/fisiopatología , Hipertensión/fisiopatología , Pene/irrigación sanguínea , Inhibidores de Fosfodiesterasa 5/administración & dosificación , Citrato de Sildenafil/administración & dosificación , Anciano , Estudios de Casos y Controles , Voluntarios Sanos , Humanos , Flujometría por Láser-Doppler/métodos , Masculino , Microcirculación , Persona de Mediana Edad , Pene/efectos de los fármacos , Flujo Sanguíneo Regional , Vasodilatación/efectos de los fármacos
11.
Braz. j. med. biol. res ; 54(6): e10577, 2021. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1285665

RESUMEN

Endothelial dysfunction is a well-known component of the pathophysiology of heart failure (HF), with proven prognostic value. Dietary supplementation with whey protein (WP) has been widely used to increase skeletal muscle mass, but it also has vascular effects, which are less understood. This study aimed to evaluate the effects of WP supplementation on the systemic microvascular function of HF patients. This was a blinded, randomized, placebo-controlled clinical trial that evaluated the effects of 12-week WP dietary supplementation on systemic microvascular function, in patients with HF New York Heart Association (NYHA) classes I/II. Cutaneous microvascular flow and reactivity were assessed using laser speckle contrast imaging, coupled with pharmacological local vasodilator stimuli. Fifteen patients (aged 64.5±6.2 years, 11 males) received WP supplementation and ten patients (aged 68.2±8.8 years, 8 males) received placebo (maltodextrin). The increase in endothelial-dependent microvascular vasodilation, induced by skin iontophoresis of acetylcholine, was improved after WP (P=0.03) but not placebo (P=0.37) supplementation. Moreover, endothelial-independent microvascular vasodilation induced by skin iontophoresis of sodium nitroprusside, was also enhanced after WP (P=0.04) but not placebo (P=0.42) supplementation. The results suggested that dietary supplementation with WP improved systemic microvascular function in patients with HF.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Anciano , Vasodilatación , Insuficiencia Cardíaca/tratamiento farmacológico , Piel , Vasodilatadores/farmacología , Endotelio Vascular , Proyectos Piloto , Suplementos Dietéticos , Proteína de Suero de Leche/farmacología , Microcirculación
12.
Braz J Med Biol Res ; 49(10): e5541, 2016 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-27599202

RESUMEN

Evaluation of microvascular endothelial function is essential for investigating the pathophysiology and treatment of cardiovascular and metabolic diseases. Although laser speckle contrast imaging technology is well accepted as a noninvasive methodology for assessing microvascular endothelial function, it has never been used to compare male patients with coronary artery disease with male age-matched healthy controls. Thus, the aim of this study was to determine whether laser speckle contrast imaging could be used to detect differences in the systemic microvascular functions of patients with established cardiovascular disease (n=61) and healthy age-matched subjects (n=24). Cutaneous blood flow was assessed in the skin of the forearm using laser speckle contrast imaging coupled with the transdermal iontophoretic delivery of acetylcholine and post-occlusive reactive hyperemia. The maximum increase in skin blood flow induced by acetylcholine was significantly reduced in the cardiovascular disease patients compared with the control subjects (74 vs 116%; P<0.01). With regard to post-occlusive reactive hyperemia-induced vasodilation, the patients also presented reduced responses compared to the controls (0.42±0.15 vs 0.50±0.13 APU/mmHg; P=0.04). In conclusion, laser speckle contrast imaging can identify endothelial and microvascular dysfunctions in male individuals with cardiovascular disease. Thus, this technology appears to be an efficient non-invasive technique for evaluating systemic microvascular and endothelial functions, which could be valuable as a peripheral marker of atherothrombotic diseases in men.


Asunto(s)
Enfermedad de la Arteria Coronaria/fisiopatología , Endotelio Vascular/fisiopatología , Flujometría por Láser-Doppler/métodos , Microvasos/fisiopatología , Imagen de Perfusión/métodos , Anciano , Estudios de Casos y Controles , Medios de Contraste , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Estudios Transversales , Endotelio Vascular/diagnóstico por imagen , Humanos , Hiperemia/fisiopatología , Masculino , Microcirculación/fisiología , Microvasos/diagnóstico por imagen , Persona de Mediana Edad , Proyectos Piloto , Reproducibilidad de los Resultados , Piel/irrigación sanguínea , Estadísticas no Paramétricas
13.
Naunyn Schmiedebergs Arch Pharmacol ; 372(1): 24-30, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16133490

RESUMEN

High glucose concentrations are involved in the development of diabetic-associated vascular complications. We have previously reported that acute high glucose challenge, corresponding to post-prandial glycemia levels observed in patients with type 2 diabetes, blunts ACh-induced endothelium-dependent relaxation of the renal circulation of non-diabetic rabbits. Isolated perfused kidneys from non-diabetic rabbits were acutely exposed (3 h) to normal (5.5 mM--control group) or high (15 mM) D-glucose concentrations in the presence or absence of a continuous infusion of metformin (20 or 100 microM). Renal vascular reactivity was evaluated with endothelium-dependent (acetylcholine, ACh) and -independent (sodium nitroprusside, SNP) vasodilating agents. ACh-induced maximal renal vasodilation was reduced by high glucose infusion (15 mM) in comparison to the control group (25+/-3% and 41+/-3% respectively; P<0.01), being restored to 41+/-4% and 43+/-2% by a simultaneous 3-h infusion of 20 or 100 microM of metformin respectively (P>0.05). Perfusion of the kidneys with the angiotensin II-converting enzyme inhibitor captopril (10 microM) also significantly prevented the deleterious effects of high glucose challenge in the renal circulation. The use of a continuous infusion of N(omega)-nitro-L-arginine methyl ester (L-NAME, 100 microM) did not affect the protective effect of metformin in the renal circulation (39+/-4%; P>0.05), while tetraethylammonium (TEA, 10 mM) partially blunted this effect (33+/-4, P<0.01). Renal vasodilation induced by SNP was not modified by simultaneous infusion of high glucose and/or metformin. It is concluded that the impairment of ACh-induced endothelium-dependent renal vasodilation observed after acute exposure to high glucose concentrations is abolished by metformin administration. These alterations of renal vascular reactivity can be accounted for, at least in part, by the activation of the renal renin-angiotensin system during hyperglycemia. The protective effects of metformin present some EDHF-dependent component and are not related to metabolic pathways dependent on nitric oxide.


Asunto(s)
Endotelio Vascular/efectos de los fármacos , Hipoglucemiantes/farmacología , Riñón/irrigación sanguínea , Metformina/farmacología , Circulación Renal/efectos de los fármacos , Vasodilatación/efectos de los fármacos , Acetilcolina/farmacología , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Animales , Captopril/farmacología , Relación Dosis-Respuesta a Droga , Femenino , Glucosa/administración & dosificación , Masculino , Perfusión , Conejos , Tetraetilamonio/farmacología , Vasodilatadores/farmacología
14.
Braz. j. med. biol. res ; 53(12): e9615, 2020. tab, graf
Artículo en Inglés | LILACS, Coleciona SUS (Brasil) | ID: biblio-1132513

RESUMEN

The sympathetic nervous system (SNS) plays a fundamental role in the pathophysiology of cardiovascular diseases, including primary arterial hypertension. In this study, we aimed to investigate whether the expression of the rate-limiting enzyme in catecholamine synthesis, tyrosine hydroxylase (TH), and the β2-adrenergic receptor (β2-AR) in immune cells from peripheral blood, reflect central SNS activity in spontaneously hypertensive rats (SHR). TH expression in the lower brainstem and adrenal glands and β2-AR expression in the lower brainstem were analyzed by western blot analyses. In the leukocytes, TH and β2-AR expression was evaluated by flow cytometry before and after chronic treatment with the centrally-acting sympathoinhibitory drug clonidine. Western blot analyses showed increased TH and β2-AR expression in the lower brainstem and increased TH in adrenal glands from SHR compared to normotensive Wistar Kyoto rats (WKY). Lower brainstem from SHR treated with clonidine presented reduced TH and β2-AR levels, and adrenal glands had decreased TH expression compared to SHR treated with vehicle. Flow cytometry showed that the percentage of leukocytes that express β2-AR is higher in SHR than in WKY. However, the percentage of leukocytes that expressed TH was higher in WKY than in SHR. Moreover, chronic treatment with clonidine normalized the levels of TH and β2-AR in leukocytes from SHR to similar levels of those of WKY. Our study demonstrated that the percentage of leukocytes expressing TH and β2-AR was altered in arterial hypertension and can be modulated by central sympathetic inhibition with clonidine treatment.


Asunto(s)
Animales , Ratas , Hipertensión/tratamiento farmacológico , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Sistema Nervioso Simpático , Tirosina 3-Monooxigenasa , Presión Sanguínea , Receptores Adrenérgicos beta 2 , Leucocitos
15.
Am J Med ; 87(3C): 10S-13S, 1989 Sep 18.
Artículo en Inglés | MEDLINE | ID: mdl-2571290

RESUMEN

The most usual hypothesis to explain the central hypotensive effect of clonidine-like substances was to admit that these drugs stimulated alpha 2-adrenoceptors within the brainstem. Now it has been demonstrated that neither the endogenous ligand to the alpha-adrenoceptors, noradrenaline, nor any other catecholamine or phenylethylamine was hypotensive in the medullary nucleus reticularis lateralis, where all imidazolines proved to be such. Recently, a membrane receptor population sensitive to clonidine and insensitive to catecholamines was described within the nucleus reticularis lateralis; this subgroup of receptors represented 20 to 30 percent of the [3H]clonidine binding sites in the bovine nucleus reticularis lateralis and 100 percent within the human nucleus reticularis lateralis region. Thus, the existence of such imidazoline specific receptors was clearly established and the endogenous ligand for those receptors, which is neither a catecholamine nor likely a peptide, is under processing for purification. Therefore, it appeared that the hypotensive effect of substances with an imidazoline or imidazoline-like structure might be due to their action within medullary receptors specific for this endogenous ligand temporarily named "clonidine displacing substance." Rilmenidine, structurally close to imidazolines, also interfered with these receptors. The central component of its hypotensive effect was recently confirmed in rabbits, where its central cardiovascular effects were antagonized by "the clonidine displacing substance." Although exhibiting a lower affinity than the reference substance for these receptors, rilmenidine might have a higher selectivity, thus explaining its restricted side effects. A structure-activity study with this molecule would bring a confirmation to these first observations.


Asunto(s)
Presión Sanguínea , Encéfalo/fisiología , Imidazoles/farmacología , Receptores Adrenérgicos alfa/fisiología , Agonistas alfa-Adrenérgicos/farmacología , Animales , Unión Competitiva , Presión Sanguínea/efectos de los fármacos , Encéfalo/efectos de los fármacos , Clonidina/metabolismo , Humanos , Imidazoles/metabolismo , Oxazoles/farmacología , Receptores Adrenérgicos alfa/efectos de los fármacos , Receptores Adrenérgicos alfa/metabolismo , Rilmenidina
16.
J Hypertens ; 10(11): 1327-34, 1992 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1336518

RESUMEN

OBJECTIVE: Our previous electrochemical studies in the normotensive Wistar-Kyoto (WKY) rat showed a positive correlation between the hypotensive effect of low doses of clonidine (2-10 micrograms/kg intravenously) and inhibition of the activity of catecholaminergic neurons within the brainstem, and that this action was mediated by imidazoline-preferring receptors. In the present study the possibility of a relationship between the centrally mediated hypotensive effect of clonidine and the metabolic activity of catecholaminergic neurons of the ventrolateral and dorsomedial medulla oblongata was investigated in pentobarbital-anaesthetized spontaneously hypertensive rats (SHR). DESIGN AND METHODS: Neuronal metabolic activity was monitored by in vivo electrochemistry in the nucleus reticularis lateralis region of the ventrolateral medulla and in the nucleus tractus solitarii region of the dorsomedial medulla oblongata. RESULTS: Hypotensive doses of intravenously administered clonidine (10 micrograms/kg) failed to inhibit the neuronal metabolic activity of the nucleus reticularis lateralis region; fivefold higher doses were required to inhibit these neurons. The low dose of clonidine (10 micrograms/kg) decreased the metabolic activity of the nucleus tractus solitarii region. Nevertheless, this effect did not appear to be correlated with a reduction in blood pressure and it was not attenuated by a prior central injection of idazoxan (5 nmol/kg intracisternally), which almost completely prevented the hypotensive and the neuronal inhibitory effects of clonidine in the nucleus reticularis lateralis region of the normotensive rat. CONCLUSION: Both the site and the mechanism of the central hypotensive action of clonidine in the SHR appear to be different from those in normotensive control WKY rats.


Asunto(s)
Presión Sanguínea/efectos de los fármacos , Clonidina/farmacología , Bulbo Raquídeo/metabolismo , Neuronas/metabolismo , Animales , Catecolaminas/metabolismo , Electroquímica , Masculino , Bulbo Raquídeo/efectos de los fármacos , Neuronas/efectos de los fármacos , Ratas , Ratas Endogámicas SHR
17.
Am J Cardiol ; 74(13): 3A-6A, 1994 Dec 22.
Artículo en Inglés | MEDLINE | ID: mdl-7998582

RESUMEN

The involvement of nonadrenergic imidazoline specific receptors in the central control of the vasomotor tone and in the mechanism of action of drugs bearing an imidazoline structure, or analogs, is now well documented. Imidazoline-specific binding sites were found in many tissues and species. Moreover, until now, it is only in the brainstem that such binding sites are associated with a function: the hypotensive effect of imidazoline-like drugs. Rilmenidine, which is an oxazoline structurally related to the reference imidazolines, exerts a central hypotensive effect of central origin involving imidazoline receptors. The selectivity of rilmenidine for the imidazoline receptors compared to alpha 2-adrenergic receptors could explain the low incidence of sedative side effects observed with this antihypertensive drug. A specific anti-imidazoline radioimmunoassay allowed us to detect the presence of an immunoreactive imidazoline-like substance in human sera. High levels of this immunoreactive substance are associated with high blood pressure in 20-30% of the hypertensive patients. This observation indicates that high levels of this immunoreactive substance in the serum can be associated with some kinds of primary hypertension. The cause-and-effect relation between these 2 phenomena has not yet been determined. This substance is in process of purification; it could be a candidate to be an endogenous ligand of the imidazoline receptors.


Asunto(s)
Fenómenos Fisiológicos Cardiovasculares , Imidazoles/metabolismo , Receptores de Droga/fisiología , Animales , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Humanos , Hipertensión/sangre , Imidazoles/inmunología , Receptores de Imidazolina , Receptores de Droga/inmunología , Sistema Vasomotor/metabolismo , Sistema Vasomotor/fisiopatología
18.
Br J Pharmacol ; 100(3): 600-4, 1990 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-2390682

RESUMEN

1. Rilmenidine has recently been introduced as a new centrally-acting antihypertensive agent. We examined its cardiovascular effects after intracerebral injection to anaesthetized rabbits. Cumulative doses of rilmenidine injected intracisternally (1 to 300 micrograms kg-1) led to dose-dependent decreases in arterial blood pressure and heart rate. The effective doses of rilmenidine were lower when injected centrally than when injected intravenously. 2. Pretreatment with the same dose of yohimbine or idazoxan shifted the rilmenidine dose-response curves for its hypotensive and bradycardic effects to the right. Idazoxan, which has an imidazoline structure, proved to be a more active antagonist than yohimbine of rilmenidine centrally-mediated cardiovascular effects. 3. The dose-response curve for the central hypotensive effect of rilmenidine was also shifted to the right after pretreatment with a bovine brain extract. This extract contains the endogenous ligand of the imidazoline-preferring receptors which is not a catecholamine. 4. Rilmenidine, like clonidine, proved to be active when micro-injected into the rabbit nucleus reticularis lateralis region. 5. In conclusion, rilmenidine exhibited in the rabbit a central hypotensive effect which originated in the same area as where clonidine acts. Specific imidazoline-preferring receptors appear to be involved in this hypotensive effect.


Asunto(s)
Antihipertensivos/farmacología , Oxazoles/farmacología , Receptores de Droga/fisiología , Animales , Antihipertensivos/administración & dosificación , Presión Sanguínea/efectos de los fármacos , Encéfalo/fisiología , Cisterna Magna , Dioxanos/farmacología , Frecuencia Cardíaca/efectos de los fármacos , Hemodinámica/efectos de los fármacos , Idazoxan , Receptores de Imidazolina , Inyecciones , Inyecciones Intraventriculares , Masculino , Oxazoles/administración & dosificación , Conejos , Rilmenidina , Extractos de Tejidos/análisis , Yohimbina/farmacología
19.
Br J Pharmacol ; 115(7): 1331-5, 1995 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-7582565

RESUMEN

1. A previous study from our group demonstrated that neurones of the paraventricular nucleus of the hypothalamus (PVN) are selectively involved in the central control of the cardiac function. Moreover, in that study, it was shown that baclofen, a selective GABAB receptor agonist, is capable of modulating the increases in myocardial contractility and oxygen demand evoked by electrical or pharmacological stimulation of the PVN. Nevertheless, the acute administration of this compound was frequently accompanied by a cardiodepressant effect. 2. In the present study, the effects of a long term treatment (14 days) with baclofen (3 or 10 mg kg-1, i.p.) have been examined on the excitatory haemodynamic responses evoked by central pharmacological stimulation in anaesthetized rabbits. 3. The i.c.v. injection of L-glutamate (3 mg kg-1) induced marked increases in dP/dtmax (32%), mean arterial pressure (39%) and on two indices of myocardial oxygen consumption: the rate-pressure product (34%) and the triple product (78%). 4. Baclofen blunted the positive inotropic response and the increases in myocardial oxygen consumption induced by L-glutamate in a dose-related manner. The higher dose of baclofen (10 mg kg-1, i.p.), reduced by more than 50% these excitatory effects of L-glutamate without eliciting any significant negative effect on basal haemodynamics. The same doses of baclofen were not able to blunt the hypertensive response induced by central stimulation. 5. These results confirm and extend our previous findings suggesting that it is possible to discriminate the central control of vasomotor tone from that of cardiac function and also that baclofen can modulate the latter. It is concluded that when given chronically, baclofen modulates the increases in myocardial oxygen demand induced by activation of the central nervous system in doses which do not depress the resting cardiac function.


Asunto(s)
Baclofeno/farmacología , Agonistas del GABA/farmacología , Corazón/efectos de los fármacos , Miocardio/metabolismo , Oxígeno/metabolismo , Animales , Femenino , Agonistas de Receptores GABA-B , Ácido Glutámico/administración & dosificación , Ácido Glutámico/farmacología , Hemodinámica/efectos de los fármacos , Inyecciones Intraventriculares , Masculino , Conejos
20.
Br J Pharmacol ; 111(4): 1347-54, 1994 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7913376

RESUMEN

1. The purpose of this study was to investigate further the role of the excitatory amino acid (EAA) system of neurotransmission, particularly of the NMDA receptor, in the central regulation of cardiac function. 2. Electrical stimulation of the paraventricular nucleus of the hypothalamus (PVN) in pentobarbitone anaesthetized rabbits induced a cardiovascular response mainly characterized by a positive inotropic effect, hypertension and a marked increase in the myocardial oxygen demand index. 3. The intracerebroventricular (i.c.v.) or intravenous (i.v.) injection of different EAA antagonists acting on different sites of the NMDA receptor/channel complex dose-dependently blunted the excitatory cardiovascular effects of PVN stimulation. 4. 5,7 Dichlorokynurenic acid was used as a specific glycine site antagonist and 2-amino-5-phosphonovaleric acid was used to block the agonist recognition site; ketamine was used as a channel blocker site antagonist and ifenprodil as a blocker of the polyamine binding site. 5. 5,7 Dichlorokynurenic acid (125 and 250 micrograms kg-1, i.c.v.) virtually abolished the cardiovascular responses, inducing only haemodynamic depression at the highest dose used. 2-Amino-5-phosphonovaleric acid (0.1 to 1.0 mg kg-1, i.c.v.) elicited a reduction of the peak values observed during PVN stimulation which was accompanied by a decrease of the basal cardiovascular parameters. Ketamine (2.5 and 10 mg kg-1) and ifenprodil (1 mg kg-1), injected intravenously, blocked the haemodynamic response induced by PVN stimulation without marked reduction of the basal haemodynamics. 6. It is concluded that glutamate neurotransmission is not only involved in vasomotor tone control but also in the central control of cardiac function and can therefore modulate the myocardial oxygen demand.


Asunto(s)
Contracción Miocárdica/efectos de los fármacos , Núcleo Hipotalámico Paraventricular/fisiología , Receptores de N-Metil-D-Aspartato/antagonistas & inhibidores , 2-Amino-5-fosfonovalerato/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , Estimulación Eléctrica , Glutamatos/metabolismo , Ácido Glutámico , Ketamina/farmacología , Ácido Quinurénico/análogos & derivados , Ácido Quinurénico/farmacología , Masculino , Conejos , Receptores de N-Metil-D-Aspartato/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA